Johnson & Johnson (JNJ)

Total Costs & Expenses

$19.03B

Quarterly · Period ending: · USD

JNJ logo

JNJ Total Costs & Expenses

Latest reported$19.03B
JNJ Quarterly Total Costs & Expenses ($0.00 → $19.03B)
High-resolution chart · PNG

JNJ total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Johnson & Johnson Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
19,034,000,000
18,136,000,000
17,667,000,000
18,973,000,000
16,897,000,000
16,933,000,000
15,594,000,000
18,679,000,000
17,193,000,000
15,790,000,000
15,110,000,000
16,788,000,000
15,153,000,000
15,161,000,000
14,648,000,000
19,801,000,000
14,332,000,000
17,548,000,000
17,308,000,000
20,329,000,000
16,472,000,000
16,954,000,000
15,473,000,000
18,303,000,000
15,143,000,000
14,179,000,000
14,845,000,000
16,405,000,000
14,840,000,000
15,152,000,000
14,692,000,000
16,176,000,000
14,640,000,000
15,309,000,000
14,281,000,000
16,903,000,000
14,933,000,000
13,431,000,000
12,242,000,000
13,483,000,000
12,436,000,000
12,776,000,000
12,030,000,000
14,428,000,000
12,459,000,000
12,870,000,000
12,028,000,000
14,310,000,000
12,890,000,000
13,525,000,000
12,469,000,000
14,283,000,000
12,700,000,000
12,811,000,000
12,561,000,000
13,995,000,000
12,748,000,000
11,874,000,000
11,575,000,000
12,951,000,000
12,085,000,000
12,269,000,000
11,572,000,000
12,202,000,000
10,960,000,000
11,034,000,000
10,864,000,000
13,154,000,000
10,818,000,000
10,885,000,000
10,377,000,000
12,145,000,000
11,830,000,000
12,194,000,000
11,449,000,000
12,783,000,000
11,007,000,000
11,253,000,000
10,839,000,000
10,749,000,000
9,660,000,000
9,967,000,000
9,239,000,000
10,162,000,000
9,054,000,000
9,325,000,000
9,007,000,000
10,088,000,000
8,239,000,000
8,055,000,000
8,102,000,000
9,051,000,000
7,585,000,000
7,444,000,000
6,911,000,000
7,389,000,000
6,569,000,000
6,531,000,000
6,131,000,000
6,873,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.